Julia Dai, M.D.
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Dermatology, McGovern Medical School at UT Health, Houston, TX
Assistant Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
Residency Program Director, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Dermatology, McGovern Medical School at UT Health, Houston, TX
Assistant Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, US, MD |
| 2009 | University of Wisconsin, Madison, Wisconsin, US, Medical Microbiology and Immunology, BS |
Postgraduate Training
| 2020-2021 | Chief Residency, Dermatology, University of Chicago, Chicago, Illinois |
| 2018-2021 | Clinical Residency, Dermatology, University of Chicago, Chicago, Illinois |
| 2016-2018 | Clinical Fellowship, Cutaneous Lymphoma, Dermatology, Stanford University, Stanford, California |
| 2015-2016 | Intern, Mount Sinai Hospital, New York, NY |
Licenses & Certifications
| 2021 | American Board of Dermatology |
| 2021 | State of Texas Medical Board |
Experience & Service
Administrative Appointments/Responsibilities
Residency Program Director, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Other Professional Positions
Faculty Director, Dermatology 4006 Medical Student Elective, UT MD Anderson, Houston, Texas, 2024 - Present
Faculty Liaison, Baylor College of Medicine, Baylor College of Medicine, Houston, Texas, 2024 - Present
Faculty Mentor, Summer in Oncology at Anderson Research (SOAR) Program, UT MD Anderson, Houston, Texas, 2024 - Present
Honors & Awards
| 2021 - 2022 | Journal of the American Academy of Dermatology Editorial Mentorship Program, American Academy of Dermatology |
| 2020 | Mentorship Award, Medical Dermatology Society |
| 2019 - 2020 | Research Grant, Chicago Dermatological Society |
| 2019 | Resident Retreat for Future Academicians,, Society for Investigative Dermatology |
| 2011 | Petrus Camper Research Fellowship,, Perelman School of Medicine at the University of Pennsylvania |
| 2010 - 2015 | Class of 1967 Scholar, Perelman School of Medicine at the University of Pennsylvania |
| 2009 | Magna cum laude, University of Wisconsin |
| 2006 - 2009 | All-State Robert C. Byrd Scholar, University of Wisconsin |
| 2006 - 2009 | Medical Scholar, University of Wisconsin |
| 2006 - 2009 | Wisconsin Letters and Sciences Scholar, University of Wisconsin |
| 2006 | National Merit Scholar |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Cutaneous T-cell lymphoma: past, present, and future. Invited. Houston Dermatology Society, Knox Memorial Lectureship. Houston, Texas, US.
- 2022. Managing complex skin conditions. Invited. MD Anderson Cancer Center Internal Medicine Grand Rounds. Houston, Texas, US.
Regional Presentations
- 2023. Updates in Oncodermatology. Invited. Dermatology Therapeutics Symposium. Austin, TX, US.
- 2023. Management of patients with cutaneous T-cell lymphoma. Invited. Dermatology Therapeutics Symposium. Austin, TX, US.
- 2023. Journal watch: AI in dermatology. Invited. Texas Dermatological Society Fall Meeting. San Antonio, TX, US.
National Presentations
- 2025. Cutaneous lymphoma or not? Clinicopathologic challenges and practical pearls. Poster. American Academy of Dermatology 2025 Annual Meeting. Orlando, Florida, US.
International Presentations
- 2024. Clinical characteristics of granulomatous cutaneous T-cell lymphoma. Poster. EORTC-CLTG Annual Meeting 2024. Lausanne, CH.
- 2021. Degos-like lesions in systemic lupus erythematosus. Invited. International Society of Dermatopathology, US.
- 2017. Anti-CCR4 antibody mogamulizumab prior to allogeneic hematopoietic stem cell transplantation in patients with mycosis fungoides (MF) and Sézary syndrome (SS): Is there an increased risk for graft-versus-host-disease related complications?. Invited. European Organization for Research and Treatment of Cancer. London, GB.
Grant & Contract Support
| Date: | 2023 - Present |
| Title: | Topical Janus kinase inhibition in early-stage mycosis fungoides |
| Funding Source: | MD Anderson Cancer Center Institutional Research Grant |
| Role: | Principal Investigator-MDACC |
| Date: | 2020 - 2021 |
| Title: | A Prospective Cohort Study Evaluating m6A RNA Methylation in Cutaneous Squamous Cell Carcinoma |
| Funding Source: | Chicago Dermatological Society |
| Role: | Co-PI |
Selected Publications
Peer-Reviewed Articles
- Lohray, R, Purnak, S, Huen, A, Duvic, M, Dai, J. Long-term outcomes in juvenile-onset mycosis fungoides. Journal of the American Academy of Dermatology 95(2):409-415, 2026. e-Pub 2026. PMID: 41780598.
- Wang, L, Curry, JL, Dai, J, Wang, DH, Strati, P, Becnel, M, Ballester, L, Torres Cabala, CA, Aung, PP. A Rare Case of Cutaneous Crystal-Storing Histiocytosis With Kappa Light Chain Restriction and Unusual BCL6 Expression. Journal of cutaneous pathology 53(8):682-686, 2026. e-Pub 2026. PMID: 41913538.
- Ibrahim, E, Dai, J, Lenskaya, V, Torres Cabala, CA, Cho, WC. Subcutaneous Panniculitis-Like T-Cell Lymphoma With Increased gd T Cells. American Journal of Dermatopathology 47(8):634-637, 2025. e-Pub 2025. PMID: 40532089.
- Wu SY, Damron EP, Xu J, Fang PQ, Dai J, Nair R, Malpica Castillo LE, Fayad LE, Torres-Cabala CA, Medeiros LJ, Vega F, Miranda RN, Duvic M, Pinnix CC, Dabaja BS, Iyer SP, Huen AO, Gunther JR. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol 64(2):385-389, 2025. e-Pub 2025. PMID: 38955474.
- Muhaj, FF, Tran, J, Dai, J, Pacha, O, Patel, A. A retrospective case series of eight patients with epidermal growth factor receptor inhibitor–induced cutaneous toxicities managed with dupilumab. JAAD Case Reports 54:17-22, 2024. e-Pub 2024. PMID: 39583056.
- Muhaj FF, Tran J, Dai J, Pacha O, Patel AB. A retrospective case series of eight patients with epidermal growth factor receptor inhibitor induced cutaneous toxicities managed with dupilumab. JAAD Case Rep, 2024. PMID: 39583056.
- Lazaroff J, Duan GY, Verghese M, Bertacchi B, Yang S, Dai J, He YY, Bolotin D. A prospective cohort study evaluating m6A RNA methylation in cutaneous squamous cell carcinoma 89(5):1083-1084, 2023. PMID: 37978975.
- Dai J, Hight RS, Grullon K, Xiao TL, Stein SL. Vitiligo-like manifestations of graft-versus-host disease in a pediatric population. Pediatr Dermatol 40(1):157-161, 2023. e-Pub 2023. PMID: 36063124.
- Foster CC, Fleming GF, Karrison TG, Liao CY, Desai AV, Moroney JW, Ratain MJ, Nanda R, Polite BN, Hahn OM, O'Donnell PH, Vokes EE, Kindler HL, Hseu R, Janisch LA, Dai J, Hoffman MD, Weichselbaum RR, Pitroda SP, Chmura SJ, Luke JJ. Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res 27(20):5510-5518, 2021. e-Pub 2021. PMID: 34168049.
- Dai J, Zha Y, Foster CC, Luke JJ, Chmura SJ, Hoffman MD. Immunotherapy-related punctate anetoderma: clinicopathologic characterization of a novel eruption. JAMA Dermatology 157(8):998-1000, 2021. e-Pub 2021.
- Kheterpal M, Dai J, Gellers S, Pulitzer M, Ni A, Myskowski PL, Moskowitz A, Kim J, Hong EK, Fong S, Hoppe RT, Kim YH, Horwitz SM. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. J Am Acad Dermatol 81(4):970-976, 2019. e-Pub 2019. PMID: 30703460.
- Sobanko JF, Dai J, Gelfand JM, Sarwer DB, Percec I. Prospective Cohort Study Investigating Changes in Body Image, Quality of Life, and Self-Esteem Following Minimally Invasive Cosmetic Procedures. Dermatol Surg 44(8):1121-1128, 2018. e-Pub 2018. PMID: 29659404.
- Sobanko JF, Dai J, Sarwer DB, Percec I. Prospective cohort study investigating changes in psychosocial functioning following minimally invasive cosmetic procedures. Dermatol Surg 44(8):1121-1128, 2018. e-Pub 2018.
- Dai J, Almazan TH, Hong EK, Khodadoust MS, Arai S, Weng WK, Kim YH. Anti-CCR4 antibody mogamulizumab prior to allogeneic hematopoietic stem cell transplantation in patients with mycosis fungoides (MF) and Sézary syndrome (SS): graft-versus-host-disease related complications. JAMA Dermatology 154(6):728-730, 2018. e-Pub 2018.
- Dai J, Belum VR, Wu S, Lacouture ME. Pigmentary alterations in patients treated with targeted cancer therapies: a systematic review of the literature and meta-analysis. J Am Acad Dermatol 77(5):902-910, 2017. e-Pub 2017.
- Dai J, Bordeaux JS, Miller CJ, Sobanko JF. Assessing surgical dermatology training in dermatology residency: a survey of dermatology program directors. Dermatology Surg 42(8):977-984, 2016. e-Pub 2016. PMID: 27347633.
- Sobanko JF, Taglienti AJ, Wilson AJ, Sarwer DB, Margolis DJ, Dai J, Percec I. Motivations for seeking minimally invasive cosmetic procedures in an academic outpatient setting. Aesthet Surg Journal 35(8):1014-1020, 2015. e-Pub 2015. PMID: 26038370.
Review Articles
- Kashyap, A, Dai, J, Ni, X. Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma. Cancers 17(4), 2025. e-Pub 2025. PMID: 40002165.
- Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
- Dai, J, Duvic, M. Cutaneous T-Cell Lymphoma. Oncology (United States) 37(2):55-62, 2023. e-Pub 2023. PMID: 36862846.
Professional Educational Materials
- Dai J, Kashyap A, Xiao N. Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma, 2025.
- Dai J, Duvic M. Cutaneous T-cell lymphoma: Current and Emerging Therapies. Oncology, 2023.
- Dai J, Almazan TH, Kim YK, Khodadoust MS. Pembrolizumab in systemic and cutaneous T-cell lymphoma. Ann Lymphoma, 2018.
- Dai J, Almazan TH, Kim YH. Cutaneous T-Cell Lymphomas. JAMA Dermatol, 2017.
Other Articles
- Lohray R, Purnak S, Dai J, Duvic M 53611 Long-term outcomes associated with juvenile-onset mycosis fungoides. J Am Acad Dermatol 91(3).
- Dai J, Belum VR, Wu S, Sibaud V, Lacouture ME Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis. J Am Acad Dermatol 77(5):902-910.e2, 2017. PMID: 28918974.
Abstracts
- Liu YA, Dai J, Nagarajan P, Torres-Cabala CA, Aung PP, Prieto VG, Cho WC. Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review. Am J Dermatopathol 45(3):185-188, 2023. e-Pub 2023. PMID: 36626570.
- Bartley B, Cho WC, Rady PL, Dai J, Curry JL, Milbourne A, Tyring SK, Torres-Cabala CA. Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21. J Cutan Pathol 50(1):47-50, 2023. e-Pub 2023. PMID: 36039682.
- Dai J, Kunder CA, Chu EY, Chan EF, Egan CL, Novoa RA. Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy. Journal of Cutaneous Pathology 44(12):1053-1056, 2017. e-Pub 2017. PMID: 28796396.
- Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic M. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD 4(276-279), 2017. e-Pub 2017. PMID: 28653029.
- Dai J, Tetzlaff MT, Schuchter LM, Elder DE, Elenitsas R. Histopathologic and mutational analysis of a case of blue nevus-like melanoma. Journal of Cutaneous Pathology 43(9):776-780, 2016. e-Pub 2016. PMID: 27152652.
- Dai J, Huen AO, Kestenbaum LA, Sarezky MD, Coughlin CC, Yan AC. Achromobacter xylosoxidans bacteremia and cellulitis: a report of a case. Pediatric Dermatology 32(4):186-187, 2015. e-Pub 2015. PMID: 25973735.
- Dai J, Micheletti RG, Rosenbach M, Chu EY. Striking follicular eruption to pegylated liposomal doxorubicin. American Journal of Dermatopathology 36(7):590-591, 2014. e-Pub 2014. PMID: 24614205.
- Dai J. Clinical characteristics of granulomatous cutaneous T-cell lymphoma. European Organisation for Research and Treatment of Cancer.
- Dai J. Anti-CCR4 antibody mogamulizumab prior to allogeneic hematopoietic stem cell transplantation in patients with mycosis fungoides and Sezary syndrome: is there an increased risk for graft-versus-host-disease related complications?. European Organisation for Research and Treatment of Cancer.
- Dai J. Degos-like lesions in systematic lupus erythematosus. International Society of Dermatopathology.
Book Chapters
- Dabaja, BS, Dai, J. Mycosis Fungoides, 1624-1646.e6, 2026.
- Dai J, Dabaja B. Mycosis fungoides. In: Gunders LL and Tepper JE, eds. Clinical Radiation Oncology. Elsevier, 2023.
- Dai J, Bolotin D. Nonmelanoma cancer of the skin. In: Kellerman RD and Rakel D, eds. Conn’s Current Therapy. Elsevier, 2020.
Letters to the Editor
- Dai J, Almazan TH, Hong EK, Khodadoust MS, Arai S, Weng WK, Kim YH. Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sezary Syndrome. JAMA Dermatol 154: 728-730, 2018.
Patient Reviews
CV information above last modified August 20, 2026